SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVDA is trending as investors brace for earnings, with the community debating whether the report will justify the stock's high valuation amid broader AI sector scrutiny. Concerns about insider selling and potential market overreaction are also fueling discussions, even with anticipation for a long-term bullish outlook following the report. Overall, sentiment is mixed as traders assess whether a beat is already priced in or if positive guidance can propel further gains.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid community discussion around the impending release of Epstein files and speculation about potential connections to prominent figures.  The community is divided, with some alleging a targeted attack against certain individuals, while others demand full transparency. Broader discussions encompass political affiliations and potential impacts on the stock.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending amid optimism surrounding deep-sea mining prospects and potential government involvement, with the CEO heading back to Washington. Community members are discussing the possibility of government stakes and key partnerships, especially with rising geopolitical tensions and the need for non-Chinese sourced minerals. Bullish sentiment seems to be fueled by the potential for significant long-term growth in the critical minerals sector.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending due to an increased share repurchase program, signaling confidence in the company's value; the community is actively discussing the potential for a buyout and the impact of the buyback on the stock's float. Despite positive news, concerns about dilution and past stock performance remain talking points, with some investors expressing skepticism towards management.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending as investors await potential LTV and CLPS contract awards, with some anticipating a surprise "golden dome" contract. Community members are closely watching for insider buying and unusual options activity, interpreting them as signals of imminent positive news. Despite recent market downturns and dilution concerns, many maintain a long-term bullish outlook, viewing current prices as a buying opportunity in the space exploration sector.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

KZIA is trending due to promising early data from a Phase 1b trial for triple-negative breast cancer, showing a significant reduction in tumor cells. The community is actively discussing the potential for a short squeeze given the low float and high short interest, while also weighing the possibility of a near-term offering. Some investors are optimistic about the drug's potential impact on cancer treatment and are anticipating further data releases.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending due to positive data from a Roche breast cancer trial, which has boosted optimism around Olema's similar treatment and sparked significant volatility. The community is discussing the potential for a short squeeze and a possible offering, with some analysts raising price targets significantly. Some traders express caution due to the lack of direct news from OLMA and the high percentage increase, suggesting a potential pump and dump.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

EOSE is trending due to a recent order from Frontier Power, viewed as validation after a short seller report, and community members are actively discussing the stock's valuation, its potential role in energy storage for AI data centers, and implications of warrant expirations. The community is also debating the impact of a registered direct offering and private placement on the company's balance sheet and future prospects, with some expressing concerns about dilution while others see it as a strategic move to fund expansion.

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Nutex Health Inc

Nutex Health is trending due to positive earnings reports and discussions around a potential short squeeze, with retail investors expressing excitement and urging others to hold. Community members are actively debating the impact of a short report from Blue Orca Capital and the company's response, as well as the significance of upcoming earnings and potential Nasdaq compliance. The broader conversation revolves around the company's financials, growth potential, and the possibility of a significant price movement.

What is Chromia? Chromia is an open source public blockchain conceived of by Swedish company Chromaway AB. The Chroma token (CHR) was launched in May of 2019. The technology behind the Chromia blockchain is adapted from an earlier technology called ‘Postchain’, a solution provided by Chromaway AB for enterprise clients.   How does Chromia work? Chromia is a standalone Layer-1 blockchain and EVM compatible Layer-2 enhancement for Binance Smart Chain and Ethereum. It is designed to enhance existing dApps and allow for the creation of next-generation dApps by providing scalability, improved data handling, and customizable fee structures. The blockchain uses a unique architecture called relational blockchain, as well as a custom programming language called Rell.  Rell is designed to code and function very similarly to SQL, allowing developers to leverage the security and immutability of blockchain while storing and handling data with the efficiency of a relational database.  Each dApp running on Chromia operates on its own sidechain which is rooted in the main blockchain. This allows each application to scale more efficiently and gives each application developer the freedom to choose from a variety of fee structures. For example, one application may require users to pay transaction fees in CHR (similar to how Ethereum or Bitcoin work), while another application could stake enough CHR to reserve computational power and allow their users to make unlimited transactions without paying any fees at all.   What applications have been built on Chromia? Chromia already has a wide variety of applications building upon their blockchain, using their chain as a decentralized storage layer, and using their Layer-2 enhancements. These applications range from DeFi options trading platform Hedget, to open world farming game My Neighbor Alice, to government land registry initiative LAC PropertyChain.  One of the latest features in development is a new NFT standard called Chromia Originals, which will operate both as a native standard on Chromia’s chain as well as an enhancement layer for existing ERC-721 and BEP-721 tokens. Work on these Layer-2 enhancements are being developed in cooperation with My Neighbor Alice.  Who is behind Chromia? Chromia’s core team consists of industry veterans Or Perelman, Henrik Hjelte and Alex Mizrahi. All three have deep roots in the crypto space, going back to the early days of Bitcoin and Ethereum. For example, Alex published several early academic papers on Proof of Stake consensus and was also one of the key figures behind Colored Coins, one of the first projects to develop the idea of ‘tokens’ that would later be brought to prominence by Ethereum.  In summary, Chromia is a Layer-1 and Layer-2 blockchain solution under active development, with the goal of delivering enhanced features and data handling and storage capabilities to decentralized applications.

Chromia

CHR is trending due to non-binding buyout proposals, with the community discussing the potential acquisition price relative to book value and cash reserves. Discussions also involve potential reverse splits, compliance with listing rules, and the possibility of the offers sparking a pump. Some traders view CHR as a China-based micro-cap with buyout potential, while others express caution due to past dilutions and reverse splits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CLSK  
✅ CLSK was in Saudi for an investment conference 
✅Jeffery Thomas used to work for Humain.  
✅Humain is partnering with @Qualcomm  to depot AI in Saudi 
✅Submer has a partnership with Saudi and UAE 
 
What do you guys think?

svw007

Frank Windust

Michou

Saber Farhi

veronica

Stuart Sklar

Michiel Adriaenssen

StockTwits Web

Cleanspark Inc

  
✅ CLSK was in Saudi for an investment conference 
✅Jeffery Thomas used to work for Humain.  
✅Humain is partnering with 

  to depot AI in Saudi 
✅Submer has a partnership with Saudi and UAE 
 
What do you guys think?